Physician profile
Lance E Landvater
NPI 1437257250
$12,793.20
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $186 · 2021: $313 · 2022: $2,885 · 2023: $8,999 · 2024: $91.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,925 · Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,925.00 |
| Food and Beverage | $165.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,752.27 | 2022-2023 | Corevalve Evolut R |
| Abbott Laboratories | $573.36 | 2020-2024 | Amplatzer Talisman, Amplatzer Amulet |
| Abiomed | $138.75 | 2019 | |
| Edwards Lifesciences Corporation | $128.25 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.03 | 2021-2022 | |
| Livanova USA, INC. | $41.98 | 2021 | |
| Medtronic Vascular, INC. | $32.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.51 | 2020 | |
| Getinge USA Sales, LLC | $21.76 | 2020 | |
| Elutia, INC. | $19.71 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.59 | 2024 | Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Landvater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.